BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24897960)

  • 1. Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.
    Parrella P; Barbano R; Pasculli B; Fontana A; Copetti M; Valori VM; Poeta ML; Perrone G; Righi D; Castelvetere M; Coco M; Balsamo T; Morritti M; Pellegrini F; Onetti-Muda A; Maiello E; Murgo R; Fazio VM
    Mol Cancer; 2014 Jun; 13():142. PubMed ID: 24897960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer.
    Wang YY; Li L; Ye ZY; Zhao ZS; Yan ZL
    World J Surg Oncol; 2015 Aug; 13():259. PubMed ID: 26311318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of microRNA-10b overexpression in breast cancer: a meta-analysis.
    Wang N; Chen P; Huang LP; Wang TZ
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer.
    Xiao H; Li H; Yu G; Xiao W; Hu J; Tang K; Zeng J; He W; Zeng G; Ye Z; Xu H
    Oncol Rep; 2014 Apr; 31(4):1832-8. PubMed ID: 24573354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer.
    Liu Z; Zhu J; Cao H; Ren H; Fang X
    Int J Oncol; 2012 May; 40(5):1553-60. PubMed ID: 22293682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-10b and minichromosome maintenance complex component 5 gene as prognostic biomarkers in breast cancer.
    Eissa S; Matboli M; Shehata HH; Essawy NO
    Tumour Biol; 2015 Jun; 36(6):4487-94. PubMed ID: 25596707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
    Ma L; Teruya-Feldstein J; Weinberg RA
    Nature; 2007 Oct; 449(7163):682-8. PubMed ID: 17898713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis.
    Liu Y; Zhao J; Zhang PY; Zhang Y; Sun SY; Yu SY; Xi QS
    Med Sci Monit; 2012 Aug; 18(8):BR299-308. PubMed ID: 22847191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-10b is a prognostic biomarker for melanoma.
    Saldanha G; Elshaw S; Sachs P; Alharbi H; Shah P; Jothi A; Pringle JH
    Mod Pathol; 2016 Feb; 29(2):112-21. PubMed ID: 26743475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of microRNA-206 in breast cancer and its association with disease characteristics and patient survival.
    Li Y; Hong F; Yu Z
    J Int Med Res; 2013 Jun; 41(3):596-602. PubMed ID: 23696595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
    Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
    Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
    Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R
    Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers.
    Chen W; Cai F; Zhang B; Barekati Z; Zhong XY
    Tumour Biol; 2013 Feb; 34(1):455-62. PubMed ID: 23238818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.
    Wang X; Li Y; Qi W; Zhang N; Sun M; Huo Q; Cai C; Lv S; Yang Q
    Oncotarget; 2015 Oct; 6(32):32737-47. PubMed ID: 26417931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-10b expression predicts long-term survival in patients with solid tumor.
    Zhang Y; Wang LJ; Yang HQ; Wang R; Wu HJ
    J Cell Physiol; 2019 Feb; 234(2):1248-1256. PubMed ID: 30191959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
    Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
    Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
    Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH
    BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.
    Pan F; Mao H; Deng L; Li G; Geng P
    Int J Clin Exp Pathol; 2014; 7(9):5622-33. PubMed ID: 25337203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.